Assistance respiratoire veino-veineuse et assistance circulatoire veino-artérielle avec oxygénation extracorporelle. Questions,réponses

A round table, organized by the French Society of Perfusion (Sofraperf) at the French national congress on extracorporeal circulations (Perfusion 2013), was attended by perfusionists, anaesthesiologists, intensivists and surgeons around the theme of respiratory veno-venous support and veno-arterial circulatory support with extracorporeal oxygenation in intensive care units. The debate was conducted in a participatory manner by bi-directional questions–answers session between moderators and assistance. The authors report management of this type of therapy that is not perfectly homogeneous, supported on literature data. Cannulae, cannulation, circuit, oxygenator, anticoagulation, control, surveillance, weaning are subject to paragraphs with defined entry whose contents are mutually enriching.     

52例α1受体阻滞剂在输尿管上段结石体外冲击波碎石术后的应用

目的探讨α1受体阻滞剂对输尿管上段结石体外冲击波碎石术(ESWL)术后辅助排石的初步经验。方法分析2006年1月至2010年5月108例输尿管上段结石ESWL患者的临床资料,患者随机分成两组:A组52例,B组56例。所有患者ESWL术后予司帕沙星0.2g,每天1次,A组接受上述治疗的同时,另加用坦索罗辛0.4mg,每日1次,所有患者日均饮水2L以上,进行日常活动。结果 A组与B组结石平均排出时间分别为4.10、6.91d,肾绞痛发生率为8%和29%,差异有统计学意义(P<0.05);结石排出率分别为82.7%、58.9%,一次ESWL后结石排净率分别为75.0%、44.6%,差异无统计学意义(P>0.05)。结论坦索罗辛可明显缩短输尿管上段结石患者的排石时间,减少肾绞痛发生次数,使用安全、痛苦少、恢复快。     

输尿管结石行体外冲击波碎石治疗后发生输尿管狭窄的危险因素分析

目的探讨输尿管结石经体外冲击波碎石治疗后发生狭窄的危险因素。方法收集2006年7月至2011年7月就诊于我院首次行体外冲击波碎石治疗的输尿管结石患者的临床资料,先对所取临床指标进行单因素分析,然后进行Logistic多因素回归分析。结果共收集行体外冲击波碎石的输尿管结石患者174例,其中发生术后输尿管狭窄的患者15例,狭窄发生率为8.62%,单因素分析显示:结石长径、肾积水程度、结石嵌顿时间以及碎石次数与术后输尿管狭窄发生相关,多因素Logistic回归分析结果显示:结石长径、肾积水程度以及碎石次数是患者发生输尿管狭窄的独立危险因素。结论对于肾积水程度较重、结石长径较大、预期碎石次数较多的输尿管结石患者,行体外冲击波碎石后发生狭窄的可能性相对较高,在治疗选择上应更加慎重,提倡选择体外冲击波碎石之外更加安全有效的治疗方式。